Keith Loria is a contributing writer to Medical Economics.
T Cell Activation Seen as Insufficient to Drive HIV Infection
Pitavastatin Can Prevent Cardiovascular Disease in HIV Infection
The Risk Of Sexual Transmission Of HIV From Individuals With Low-Level HIV Viremia
Hip Replacement OK for HIV Patients
Some orthopedic surgeons have been reluctant to perform total hip arthroplasty on people with HIV/AIDS. Researchers at UT Southwestern Medical Center found no additional risks from HIV per se.
Gilead’s Sunlenca Tops Other Drugs in Heavily Treated People with HIV
The company-sponsored study compared Sunlenca (lenacapavir) with Rukobia (fostemsavir) and Trograzo (ibalizumab).
Protocol Deviations In South Africa’s Largest HIV Vaccine Efficacy Trial
When addressing errors, researchers focused on the individual who made the error and retraining. Lead author Fatima Laher says attention should be shifted to root cause analysis and process improvement.
Hiding Out in the Brain: Microglia Harbor Stable, Replication-Competent HIV
University of North Carolina researchers found stable and replication-competent HIV in the microglia in the brain even in people with HIV who had been taking antiretroviral therapy for a long time.
Immune Checkpoint Inhibitors Study for People Living With HIV Shows Promising Results
Researchers and clinicians have been wary of treating people living with HIV with Keytruda, Opdivo and other immune checkpoint inhibitors because removing an inhibitory step in the immune response was seen as risky for people with compromised immune systems.
Tennessee Rejects Federal HIV Prevention Funds, Funding Rerouted Through United Way
$11.6M Grant Will Enable Researchers to Study Cannabis Use Among Those Living with HIV
Cannabis may accentuate the effects of HIV on the brain or perhaps may mitigate them because of its anti-inflammatory properties.
On Long-Term Treatment, Piggybacking on Hepatitis C Eradication and the ‘Biggest Buzz' in HIV: A Conversation with Angel I. Ribó, PA-C, MPAS
Ribó is the faculty advisor to new POCN Center for HIV Excellence that will provide information and resources to providers who may see relatively few patients with HIV.
Australian Study Shows Benefits of HIV Treatment on Incidence
‘Yes, PrEP is very important and very useful, but its use is complemented extremely by HIV treatment, so you really have to do both,’ says researcher.
Study on Statins Impact on Cardiovascular Prevention in People With HIV Halted
Is Medicare Advantage a Disadvantage For Patients With Cancer?
Medicare Advantage plans have been associated with increased screening rates. But managed care tactics and narrow networks may be a disadvantage for people needing care.
HIV Stays Controlled in These Individuals Even After They Stop Treatment. Understanding Why Could Provide Clues to a ‘Functional Cure'
A team of researchers studied 22 HIV 'post-treatment controllers' — people whose HIV infections are kept in check even after stopping antiretroviral therapy.
Tight Control of HIV Associated With Lower Heart Failure Risk
A Kaiser Permanente study shows a close link between HIV RNA levels and low CD4 counts and the risk of heart failure.
German Man Cured of HIV With Stem Cells
Stem cell transplants are not being proposed as treatments for HIV, but this case and a handful of others offer promising confirmation that HIV is not entirely incurable.
Examining Adverse Pregnancy Outcomes in People Living with HIV
The known benefits of antiretroviral therapy (ART) in pregnant persons living with HIV outweigh the risks, which include low-birth weight and metabolic complications for the pregnant person, says the lead author of a review article ART and adverse outcomes published in the New England Journal of Medicine.
New Quick-Dissolving Antiviral Insert Placed In The Rectum Could Help Prevent HIV
Researchers report positive result from a phase 1 trial that show the presence of the antiviral medication in rectal tissue.
Project HOPE Leader Nagesh Borse on the Importance of Renewing PEPFAR
The Perfect PrEP: Long Acting, No Side Effects, No Out-of-Pocket Expense and Nearby
Uptake of pre-exposure prophylaxis (PrEP) has been slow. A survey shows that safety and side effects are the top concerns.
Esophageal Cancer Update
Gastroesophageal reflux disease is a risk factor for what is now the more common type of esophageal cancer, adenocarcinoma. Immunotherapy is coming on strong as a treatment.
Funding Awarded for Study of HIV and Gum Disease
Tulane University researchers are studying whether dysregulation of the oral microbiome might affect HIV outcomes. They are using rhesus monkeys and SIV infection as a model.
NCI Study Analyzes the Harms From Cancer Screening
The researchers have several suggestions for how harm from screening should be reported in screening guidelines.
Study Examines Immune System of MS Patients Who Undergo Stem Cell Transplant
Results of research by Swiss investigators show effector memory T cells bounce back quickly after autologous hematopoietic stem cell transplantation.
HIV and AIDS in Florida, the State of Play
Florida has among the largest populations of people living with HIV in the country. We spoke with a clinician with 40 years of experience taking care of Floridians with HIV.
Study Looks at How an HIV Protein Can Alter Immune Cells and Fuel Chronic Inflammation
Research results published in Cell Reports implicate the Nef protein as a possible cause of disease-causing inflammation that persists even when an HIV infection is controlled.
Howard University Professor Awarded Grant to Harness Nanotechnology for HIV Cure
HIV hides out and replicates in the spleen, the lymph nodes and other reservoirs. Emmanuel Okala hopes to develop nanotechnology that will flush it out.
Anxiety Linked to Bedtime Procrastination
University of Arkansas researchers added to the understanding of how anxiety affects sleep with research that looked for associations between anxiety and bedtime procrastination and other patterns of poor sleep.
Atomoxetine, Oxybutynin Combination Shows Some Promise as a Treatment for Obstructive Sleep ApneaKey to Treating OSA
2 Clarke Drive Cranbury, NJ 08512